Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support
Launched by KAFRELSHEIKH UNIVERSITY · Oct 12, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain best practices can help prevent nasal pressure injuries in premature babies who need non-invasive respiratory support. These babies, born between 30 and 37 weeks of gestation, often require help with breathing due to conditions like respiratory distress syndrome. The trial is currently looking for participants, and it is open to all genders.
To be eligible for this study, babies must be preterm and receiving non-invasive respiratory support, but those with existing nasal injuries, those who have had surgery, or those with certain respiratory issues cannot participate. Families who join the study can expect to follow specific care practices designed to protect their baby's nose from injury during treatment. This research is important because it aims to improve the care and comfort of vulnerable preterm infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm neonates receiving NIRS
- • whose gestational ages ranges between 30 and 37 weeks, and both genders
- Exclusion Criteria:
- • all preterm neonates not receiving NIRS,
- • have prior nasal trauma caused by tracheal intubation
- • or Infants exhibiting evidence of nasal damage during the NIRS procedure,
- • have upper respiratory abnormalities.
- • preterm neonates who have undergone any type of surgery and had life-threatening congenital abnormalities.
About Kafrelsheikh University
Kafrelsheikh University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that contribute to the enhancement of healthcare practices and patient outcomes. With a strong emphasis on interdisciplinary collaboration, the university harnesses its diverse expertise in medical sciences, engineering, and technology to conduct rigorous clinical studies. Kafrelsheikh University aims to foster innovation in clinical research, ensuring compliance with ethical standards and regulatory requirements, while actively engaging in community health initiatives to address pressing health challenges. Through its commitment to excellence, the university seeks to develop evidence-based solutions that improve health and well-being at both local and global levels.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kafr Ash Shaykh, Kafr El Sheikh, Egypt
Patients applied
Trial Officials
Eman W Wardany, ass. professor
Principal Investigator
pediatric nursing department, faculty of nursing kafrelsheikh univeristy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported